About
Licensing & Collaborative Opportunities
Brain Computer Interface
Cancer
Cut-N-Glo
EEG Brain Function Measurement
eFINDS – Evacuation of Facilities in Disasters System
Epilepsy or Tumor Resection Surgery using Passive Brain Mapping
IU1 Inhibits Dengue virus replication
Mouse anti-bat mAb
Zika Diagnostic Assay
Pathogen Detection using a Flexible Substrate Sensor System
SCID Newborn Screening
Self-Cleaving Inteins
Sfold software
Spinal Cord Reflex Neurorehabilitation
West Nile & Dengue Screening
West Nile Virus Diagnostic MIA
By partnering with public and private institutions HRI delivers the resources necessary to translate research findings into products for the prevention, diagnosis and treatment of disease.
HRI has a long and distinguished history of recognizing, protecting and developing novel technologies. Successful transfers include a number of major medical technologies such as the prostate specific antigen (PSA) test, photodynamic cancer therapy, pox virus vectors, a diagnostic assay for HIV tropism, and the blood thinner Angiomax.
